Bristol-Myers inks 10-year CMO deal; AstraZeneca picks Dotmatics for virtual neuro biz;

> Bristol-Myers Squibb ($BMY) has signed a 10-year deal with CMO Samsung BioLogics, tasking the South Korean company with producing a cancer drug. More

> AstraZeneca ($AZN) has recruited another contractor to its nearly all-outsourced neuroscience unit, this time linking up with clinical IT outfit Dotmatics. Story

> Lonza is phasing out a troubled Massachusetts manufacturing plant, part of its efforts to cut costs and trim 250 jobs. Article

> Aesica has appointed a new chief operating officer, tasking Chris Gowland with overseeing all of its manufacturing sites. Report

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.